Monday, February 28, 2022
Rare Disease Day
Monday, February 21, 2022
Sunday, February 20, 2022
Friday, February 18, 2022
Thursday, February 17, 2022
Monday, February 14, 2022
Sunday, February 13, 2022
Internet Friends Day
The Relay For Life Community Facebook Group is volunteer-led where Relayers can come to find inspiration, share ideas and tips for successful fundraising events, ask each other questions, and seek advice.
Friday, February 11, 2022
International Day of Women and Girls in Science History
Thursday, February 10, 2022
Wednesday, February 9, 2022
Tuesday, February 8, 2022
President Biden announces reignition of Cancer Moonshot
ACS and ACS CAN leadership attend White House event.
President Biden on Feb. 2 announced the reignition of the Cancer Moonshot, an initiative to “end cancer as we know it.” The initiative will build on the extensive work and robust investment of the initial cancer moonshot investment in discovery, prioritizing increasing cancer screening rates, and addressing health disparities.
Dr. Karen E. Knudsen, CEO of the American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN), and Lisa Lacasse, president of ACS CAN, joined President Biden, First Lady Dr. Biden, Vice President Harris and Second Gentleman Douglas Emhoff at the White House for an event on the initiative.
The initiative intends to harness the power of the federal government to reduce the death rate from cancer by at least 50 percent over the next 25 years, as well as improve the experience of people and their families living with and surviving cancer. Key elements include a call to action to increase cancer screening rates, and an emphasis on helping ensure that everyone in the United States equitably benefits from the tools available to prevent, detect, treat and survive cancer.
Declines in overall cancer death rates can be directly traced to investment in research, advocacy and direct patient support. ACS and ACS CAN applauded the President for putting national focus on changing the trajectory of a disease that is projected to kill more than 600,000 people in the U.S. this year. The goals of the Cancer Moonshot directly align with the work ACS and ACS CAN are leading to accelerate discovery, improve access to patient services and advance public policy. Both organizations have pledged to continue to stand shoulder to shoulder with the president continuing this work that will help reduce death and suffering from cancer.
ACS and ACS CAN have prioritized cancer prevention and early detection and health equity. A few examples of this work include:
- ACS’ Get Screened campaign, which is raising awareness of the importance of cancer prevention
- $2.2 million in ACS grant funding to rapidly increase cancer screening rates and reduce barriers exacerbated by the pandemic
- ACS CAN’s advocacy work to protect funding for breast and cervical cancer programs that serve uninsured and underinsured individuals
- ACS CAN’s support of policies that increase diversity in clinical trials
- $65 million ACS has invested to date in health disparities research
- The Diversity In Cancer Research program, which supports ACS’ efforts to foster a more diverse scientific workforce community.
- ACS’ Partnering For Life initiative, which spreads awareness about cancer risk, prevention, and early detection in the Black community.
In 2016, then President Obama tasked then Vice President Biden with heading up the initial national Cancer Moonshot effort. The original objective of the initiative was to make a decade’s worth of progress in five years. ACS and ACS CAN played key roles in supporting the initial national Cancer Moonshot effort. ACS CAN endorsed and advocated for the 21st Century Cures Act, enacted in December 2016, authorizing $1.8 billion in funding for the Cancer Moonshot over 7 years to be appropriated each fiscal year over 7 years, starting in 2017. Former ACS Chief Medical and Scientific Officer and Executive Vice President Otis Brawley, M.D. served on the Cancer Moonshot Implementation Science Working Group. Since 1991, ACS alone has invested over $3 billion in cancer research.
*Shared from MySocietySource.
Monday, February 7, 2022
Saturday, February 5, 2022
American Heart Month
Friday, February 4, 2022
World Cancer Day
ACS is collaborating with volunteers, partners & projects in 57 countries.
Today the American Cancer Society (ACS) is joining the global cancer community in recognizing World Cancer Day. The day aims to raise awareness, improve education, and catalyze personal, collective, and government action to reimagine a world where millions of preventable lives are saved and access to life-saving cancer treatment and care is equitable for all – no matter who you are or where you live.
Cancer is responsible for 1 in 6 deaths worldwide each year – more than HIV/AIDS, tuberculosis, and malaria combined. And, it has a disproportionate impact on low- and middle-income countries (LMICs), with about 70% of cancer-related deaths occurring in these areas.
On World Cancer Day (and every day!), ACS is committed to leading the fight for a world without cancer. Health equity is at the core of our work, and we have both a responsibility and an unparalleled opportunity to harness our 100+ years of experience, expertise, and ingenuity to make an impact. ACS has a large global footprint with volunteers, partners, and projects in 57 countries around the world all collaborating to reduce disparities in cancer outcomes.
Our global work prioritizes convening and supporting ministries of health, civil society organizations, and health care systems in LMICs to strengthen capacity and infrastructure across the cancer care continuum and achieve a more promising.
We are making an impact in the lives of people around the world:
- Developed 49 cancer treatment guidelines through partnership with the National Comprehensive Cancer Network for Sub-Saharan Africa, covering 88% of cancer patients in the region.
- Signed agreements with Pfizer, Novartis, Biocon, and Viatris to offer products to African purchasers at prices that are less than half of current prices. The agreements cover 26 medications in 39 formulations that are part of recommended treatment regimens for 30 cancers.
- Developed a mobile app for safe handling of chemotherapy that cancer centers can use to complete an end-to-end facility assessment and find resources to bring their practice in alignment with international standards.
- Trained more than 25,000 health care workers in Africa in the safe use of opioids for pain relief as part of our Pain-Free Hospital Initiative
- In December 2020, ACS graduated the second cohort of cancer organizations in Kenya and Uganda from the SOURCE Program, a comprehensive organizational development program.
- In 2020, the SOURCE Program East Africa ECHO Clinic was piloted with 174 total unique participants and an average attendance of 70 individuals per session.
And this year, we are launching the BEACON Global Patient Navigation Toolkit and Peer Learning Collaborative in eight countries: Armenia, Brazil, Egypt, Guatemala, Indonesia, Malaysia, Nigeria, and South Africa.
What you can do
Our masterbrand social media channels will be posting about World Cancer Day, so feel free to engage with and share that content. Our call to action? Learn more about our global work by visiting cancer.org and donate today.
To learn more about the global cancer burden, check out Global Cancer Facts & Figures.
*Shared from MySocetySource.
Wednesday, February 2, 2022
National Cancer Prevention Month